Overexpression of c-met in the early stage of pancreatic carcinogenesis; altered expression is not sufficient for progression from chronic pancreatitis to pancreatic cancer

Figure 2 We performed quantitative real-time RT-PCR to quantify c-met expression in pancreatic cancer tissues (n = 11), normal pancreatic tissues (n = 20), and chronic pancreatitis tissues (n = 15). c-met was overexpressed in pancreatic cancer tissues in comparison to expression in normal pancreatic (P = 0.0017) and chronic pancreatitis tissues (P = 0.0047). Levels of c-met did not differ between normal pancreatic and chronic pancreatitis tissues (P = 0.4433).